OncoMed Pharmaceuticals Inc 4 SEC Filings

Filed On	Filing
23 Apr 2019	Form 4: Hager Alicia J., SVP and General Counsel Disposed of 39,488 shares (Tender Offer)
23 Apr 2019	Form 4: Root Jonathan D, Director Disposed of 121,020 shares (Tender Offer)
23 Apr 2019	Form 4: Lasersohn Jack W, Director Disposed of 1,685,913 shares (Tender Offer)
23 Apr 2019	Form 4: Lewicki John A., Director Disposed of 142,534 shares (Tender Offer)
23 Apr 2019	Form 4: Pakianathan Deepika, Director Disposed of 2,010,542 shares (Tender Offer)
23 Apr 2019	Form 4: Li Yvonne, See Remarks Disposed of 65,895 shares (Tender Offer)
23 Apr 2019	Form 4: Stagg Robert, See Remarks Disposed of 28,917 shares (Tender Offer)
23 Apr 2019	Form 4: Karsen Perry A, Director Disposed of 80,500 shares (Tender Offer)
26 Dec 2018	Form 4: Gurney Austin, See Remarks Sold 11,117 shares ($6.67K)
11 Oct 2018	Form 4: Stagg Robert, SVP, Clinical R&D Sold 927 shares ($1.86K)
11 Oct 2018	Form 4: Li Yvonne, See Remarks Sold 927 shares ($1.87K)
11 Oct 2018	Form 4: Gurney Austin, See Remarks Sold 1,156 shares ($2.32K)
11 Oct 2018	Form 4: Hager Alicia J., SVP & General Counsel Sold 1,156 shares ($2.34K)
11 Oct 2018	Form 4: Lewicki John A., Director Sold 1,156 shares ($2.32K)
10 Oct 2018	Form 4: Li Yvonne, See Remarks Sold 1,229 shares ($2.62K)
10 Oct 2018	Form 4: Gurney Austin, See Remarks Sold 1,686 shares ($3.59K)
10 Oct 2018	Form 4: Stagg Robert, SVP, Clinical R&D Sold 1,686 shares ($3.59K)
10 Oct 2018	Form 4: Lewicki John A., Director Sold 2,296 shares ($4.89K)
10 Oct 2018	Form 4: Hager Alicia J., SVP & General Counsel Sold 1,686 shares ($3.59K)
25 Jun 2018	Form 4: Wyzga Michael S, Director Granted 15,000 Stock Option (Right to Buy)

Comments